Screening method of stabilized immunoglobulin variable domain and application of screened domain
KR20150076772A
Expression vector having an improved gene expression level
KR20150074904A
Method for producing human complement factor h
KR20150074922A
Deletion form of human complement factor h and use thereof
KR101370512B1
Mdck-derived cell lines suspension-cultured in a protein-free medium and method for propagating virus using the same
WO2013168965A2
Vaccine composition for preventing staphylococcus aureus infection
CN104769113A
Screening and engineering method of super-stable immunoglobulin variable domains and their uses
KR20130110948A
Broad protective efficacy of t cell-based universal influenza vaccine
EP2679683A2
Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
WO2012067427A2
Pharmaceutical composition containing lk8 protein as an active ingredient for preventing or treating diabetic retinopathy or age-related macular degeneration
KR20120091978A
Full genome dna of human cytomegalovirus strain jhc isolated from a korean patient and open reading frames thereof
KR20110005667A
Method for reducing fucose contents of recombinant proteins
KR20100109542A
Method for preparing hematopoietic stem cells having improved engraftment
CN102844329A
Hexon isolated from simian adenovirus serotype 19, hypervariable region thereof and chimeric adenovirus using the same
US2011129872A1
Method for a production of a recombinant protein using yeast co-expression system
KR20110024082A
Method for detecting peptide nucleic acids
US2009162317A1
Polynucleotide encoding HCV epitopes which can bind to various HLA supertypes, immunogenic composition comprising same and method of inducing an HCV-specific immune response using same
KR20090047353A
Multivalent prophylactic vaccine for preventing hcv and hbv infection
US2011008885A1
Linear double-stranded rna molecule interfering with different target genes
KR20100004359A
Method for reducing fucose contents of recombinant proteins
